Hormone Sensitive Prostate Cancer trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Hormone Sensitive Prostate Cancer trials nationally

1

Recruiting in Illinois

3

Cities with sites

Cities in Illinois

Chicago Ridge 1Decatur 1O'Fallon 1

Recruiting trials in Illinois

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT07028853 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Illinois: Chicago Ridge, Decatur, O'Fallon

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.